KEYNOTE-183 trial of pembrolizumab in multiple myeloma: trial design and rationale
Translational research in Berlin to improve AML treatment outcomes
Smoothening the spines: hedgehog signaling inhibitor glasdegib combinations for AML
Myeloma highlights from ASCO 2017
Where will leukemia research go next?